Generic Drug Archives - SCIENCE UNFILTERED

https://www.googleoptimize.com/optimize.js?id=OPT-T3HPS7B

FeaturedOur CompanyPharma / BiopharmaTechnical Tips

Biosimilars, Generic Drugs, and the Pharmaceutical Industry

December 18, 2018December 18, 2018 Science UnfilteredLeave a comment

biosimilars

Author: Chad Eichman, PhD – BioPharmaceutical Global Marketing Manager How Biosimilars are Affecting the Pharmaceutical Industry Honey Nut Cheerios™ or Honey Nut Tasteeos®? Glad® Trash Bags or Walmart’s Great Value™ Continue Reading

Tagged active pharmaceutical ingredient,API,Bioanalytical,Biochemistry,Biological,biologics,biologics analysis,biopharm,biopharmaceuticals,Biosimilar,biosimilars,bioZen,BPCI Act,Chromatographic,Chromatography,chromatography today,drug industry,FDA,Generic Drug,Generic Drugs,Generics,Immunobiology,immunogenicity,large molecule drugs,large molecules,pharmaceutical industry,Pharmaceuticals,small molecules,small organic molecule,Small Particles

Fun ScienceLiquid Chromatography (LC)Pharma / Biopharma

Allowable Adjustments to Pharmacopoeia Methods: Simplified Version

January 8, 2016August 16, 2017 Science UnfilteredLeave a comment

Effective August 2014, the United States Pharmacopoeia and the National Formulary published the latest revision to General Chapter on Chromatography that further clarifies what “allowable adjustments” can be made to USP methods without having to revalidate these methods.

Tagged Allowable Adjustment,Allowable Adjustments,Chromatogram,Chromatograms,Chromatographer,Chromatographers,Chromatography,Drug,Drugs,EP,European Pharmacopoeia,Generic Drug,Generic Drugs,Liquid Chromatography (LC),Monograph,Monographs,National Formulary,NF,Pharmacopoeia,Phenomenex,The National Formulary,The United States Pharmacopoeia,UHPLC,United States Pharmacopoeia,USP

Close